The Science Behind Tirzepatide
The bottom line GLP-1 drugs are not a replacement for insulin, and they are not officially approved for T1D (outside of the new 2026 ADA recommendation for T1D with obesity)
New for fiscal year 2025: ICD-10-CM instructional notes specify to use an additional code for the patients hypoglycemia level with E16.A1, E16.A2, and E16.A3 when the physician documents diabetes with hypoglycemia. Coding Poisoning, Adverse Effects, Underdosing When coding any medication, including those used to treat diabetes, adverse effects and under- or overdosing often come into the clinical picture
Expert Medical Team : Our licensed providers offer safe, medically monitored treatment so you can feel confident at every step
Wolever TMS, Jenkins AL, Prudence K, Johnson J, Duss R, Chu Y et al